In addition, the frequency of CD39+CD4+ T cells in CLL patients with cytogenetic abnormalities with poor prognosis is also similar to that in patients with normal- or low- or moderate-risk cytogenetic abnormalities (73). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.